Browse EX-10 agreements

DISTRIBUTORSHIP AGREEMENT

THIS AGREEMENT, effective as of 29th of March 2024 (“Effective Date”), entered into between:

	(A)	Taiwan Biotech Co., Ltd.., a company incorporated under the laws of Republic of China and having its office at 22, Jie-Shou Rd., Taoyuan City, Taiwan, R.O.C. and its related affiliates hereinafter called (“TBC”)

…

FIRST AMENDMENT TO

DISTRIBUTORSHIP AGREEMENT

This First Amendment to Distributorship Agreement (this “Amendment”) is made and entered into as of 30th September 2025 (the “Effective Date”), by and between:

Between

Cubebio Co., Ltd.,

8F HYHILL Building, Digital-ro 10-gil 9,

Gemcheon-gu, Seoul,

Korea

(“Cubebio”)

and

Firstlink Healthcare Asia LTD.

Room B, 17/F, Loyong Court,

212-220 Lockhart Road,

wanchai, Hong Kong

(“Firstlink”)

CUBEBIO and FIRSTLINK are each a “Party” and together the “Parties.”

RECITALS

	A.	The Parties entered into a Distributorship Agreement dated 11th November 2022 (the “Original Agreement”), pursuant to which CUBEBIO appointed FIRSTLINK as the exclusive distributor of the PRODUCTS in the Territory.

…

DISTRIBUTORSHIP AGREEMENT

THIS AGREEMENT, effective as of 11th of November, 2022 (“Effective Date”), entered into between:

	(A)	Firstlink Healthcare Asia Limited, a company incorporated under the laws of Hong Kong and having its office at Room B, 17/F, Loyong Court, 212-220 Lockhart Road, wanchai, Hong Kong and its related affiliates hereinafter called (“Firstlink”)

…

KO REA A D M I N I STR A TI V E SCR I VENE R S & CE R TI F IED P U B LIC TR A N S L A T O RS A SS O C I A T I O N K o r e a T r a ns l a tor s A d minist ra tive S c ri ve n e r P U BL IC T R AN S L A T O R’S F O R M P T F 1 0 1 ( R E V . 0 1 - 0 1 - 2 0 1 3 ) O f f i c e o f K o r e a A d m i n ist r a ti v e S c r i v e n e r 1 0 1 2 1 0 mm ⅹ 297 m m N u m b er o f i ss u e: 4 6 3 4 0 C E R T I F I C A TE O F T RA N SL A T I O N C o n s i g n m e n t a n d T r u s t A g re e m e nt T it l e o f D o c u m e nt ( D e s c r i p t io n o f S er vi ce) C U B E B I O C o . , L t d .: C O S M A X P H A RM A C o . , L t d. N ame o f C u st o m er I , G I C HOUL , C HO I , s ign e d b e lo w , HE R E BY C E R TI F Y th a t t h e a tt ac h e d do c um e nts we r e p r e p are d a nd t ra nsl a t e d by mys e lf a t t h e r e qu e st o f the p er son n a m e d a bove a n d th a t the t ra nsl a tion is t r ue a nd acc u r a te to the o r igin a l d o c um e nt . T he t ra nsl a t e d do c um e n t ( s) submitt e d to you ( a g e n c y) is/ a r e acc u ra t e ly a nd fa i r ly a utho r i ze d t ra n sl a tion ( s) acc o r ding to the O f f i c i a l T ra nsl a tion A dminist ra tive O f f i c e of the R e public of K o rea ’ s L i ce ns e d A dminist ra tive A g e nt A c t ( I t e m 3 a nd 4 , P ara g ra p h 1 , Ar ti c le 2 ) . A R e gist ere d Public T r a nsl a tor is a utho r i ze d to t ra nsl a te f o re ign/ K o rea n do c um e nts submitt e d to a nd fr om f o re ign/ K o r e a n G ov e r nm e nt O f f i c e s a nd its re l e v a nt a utho r iti e s fr om f o re i gn l a ngu

…

Forte Biosciences, Inc.

Amended and Restated Non-Employee Director Compensation Policy

(April 28, 2026)

Each member of the Board of Directors (the “Board”) who is not also serving as an employee of or consultant to Forte Biosciences, Inc. (“Forte Biosciences”) or any of its subsidiaries (each such member, an “Eligible Director”) will receive the compensation described in this Amended and Restated Non-Employee Director Compensation Policy for his or her Board service. This policy is effective as of April 28, 2026 (the “Effective Date”) and may be amended at any time in the sole discretion of the Board or the Compensation Committee of the Board.

Annual Cash Compensation

The annual cash compensation amount set forth below is payable in equal quarterly installments, payable in arrears on the last day of each fiscal quarter in which the service occurred. If an Eligible Director joins the Board or a committee of the Board at a time other than effective as of the first day of a fiscal quarter, each annual retainer set forth below will be pro-rated based on days served in the applicable fiscal quarter, with the pro-rated amount paid for the first fiscal quarter in which the Eligible Director provides the service, and regular full quarterly payments thereafter. All annual cash fees are vested upon payment.

1. Annual Board Service Retainer:

a. All Eligible Directors: $42,500

b. Chairman of the Board Service Retainer (in addition to Eligible Director Service Retainer): $30,000

…

fIRST AMENDMENT TO EMPLOYMENT AGREEMENT

This first AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”), is entered into as of August 11, 2026 (the “Effective Date”), by and between Todd Fagan (the “Executive”) and Q/C Technologies, Inc., a Delaware corporation (the “Company”), for the purpose of amending that certain Employment Agreement, dated as of March 16, 2026 by and between the Executive and the Company (the “Employment Agreement”). Terms used in this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed to such terms in the Employment Agreement.

WHEREAS, Article V.G of the Employment Agreement provides that the Employment Agreement may be amended, modified, or waived only with the prior written consent of the Company and the Executive; and

WHEREAS, the parties mutually desire to modify certain provisions that would otherwise apply to Employee’s title pursuant to the Employment Agreement.

NOW, THEREFORE, pursuant to Article V.G of the Employment Agreement, in consideration of the mutual provisions, conditions, and covenants contained herein, and other good and valuable consideration, the adequacy of which is hereby acknowledged, the parties hereby agree as follows:

…

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (this “Agreement”), effective as of March 16, 2026 (the “Effective Date”), is entered into by and between Todd Fagan (the “Executive”) and Q/C Technologies, Inc. (the “Company”). The Company and the Executive shall be referred to herein as the “Parties” and each as a “Party.” This Agreement terminates and supersedes in its entirety that certain Consulting Services Agreement effective as of November 4, 2025 (the “Prior Agreement”).

** **

RECITALS

WHEREAS, the Executive currently provides financial consulting services to the Company pursuant to the terms of that certain Prior Agreement as the assigned resource on behalf of Morice Layton & Fagan, LLC;

Whereas, the Company desires to employ the Executive as its Controller, and the Executive desires to be employed by the Company as its Controller effective as of the Effective Date; and

Whereas, the Company and the Executive desire to state in writing the terms and conditions of their agreement and understandings with respect to the employment of the Executive on and after the Effective Date.

Now, Therefore, in consideration of the mutual promises and agreements contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the Parties hereby agree as follows:

ARTICLE I.

Services to be Provided by Executive

…

AMENDMENT

** **

TO

** **

INTELLINETICS, INC. 2023 NON-EMPLOYEE DIRECTOR COMPENSATION PLAN

This Amendment to the Intellinetics, Inc. 2023 Non-Employee Director Compensation Plan (this “Amendment”) is made by Intellinetics, Inc., a Nevada corporation (the “Company”), as of April 30, 2026. Capitalized terms used and not otherwise defined herein shall have the respective meanings ascribed to them in the Plan (as defined below).

WHEREAS, the Board of Directors (the “Board”) and the shareholders of the Company previously adopted and approved the Intellinetics, Inc. 2023 Non-Employee Director Compensation Plan (the “Plan”);

WHEREAS, pursuant to Section 6.1 of the Plan, a total of 150,000 shares of the Company’s common stock, par value $0.001 per share, have been reserved for issuance under the Plan, subject to further adjustments as set forth in Section 6.9 of the Plan;

WHEREAS, the Company desires to increase the total number of shares of common stock issuable under the Plan from 150,000 shares to 302,863 shares, including shares previously issued thereunder;

WHEREAS, Section 8.8 of the Plan permits the Board to amend the Plan from time to time, subject only to certain limitations specified therein;

NOW, THEREFORE, the Board has amended the Plan as follows, subject to approval by the stockholders of the Company:

1. The first sentence of Section 6.1 of the Plan is hereby amended and restated in its entirety to read as follows:

…

AMENDMENT

** **

TO

** **

INTELLINETICS, INC. 2024 EQUITY INCENTIVE PLAN

This Amendment to Intellinetics, Inc. 2024 Equity Incentive Plan (this “Amendment”) is made by Intellinetics, Inc., a Nevada corporation (the “Company”), as of April 30, 2026. Capitalized terms used and not otherwise defined herein shall have the respective meanings ascribed to them in the Plan (as defined below).

WHEREAS, the Board of Directors (the “Board”) and the shareholders of the Company previously adopted and approved the Intellinetics, Inc. 2024 Equity Incentive Plan (the “Plan”);

WHEREAS, pursuant to Section 4.1 of the Plan, a total of 243,122 shares of the Company’s common stock, par value $0.001 per share, have been reserved for issuance under the Plan, subject to further adjustments as set forth in Section 11 of the Plan;

WHEREAS, the Company desires to increase the total number of shares of common stock issuable under the Plan from 243,122 shares to 771,557 shares, including shares previously issued thereunder;

WHEREAS, the Company desires to increase the total number of shares of common stock for which Incentive Stock Options may be granted from 243,122 shares to 771,557 shares;

WHEREAS, Section 16 of the Plan permits the Board to amend the Plan from time to time, subject only to certain limitations specified therein;

NOW, THEREFORE, the Board has amended the Plan as follows, subject to approval by the stockholders of the Company:

1. Section 4.1 of the Plan is hereby amended and restated in its entirety to read as follows:

…

Annexon, Inc.

Non-Employee Director Compensation Program

This Annexon, Inc. (the “Company”) Non-Employee Director Compensation Program (this “Program”) has been adopted under the Company’s 2020 Incentive Award Plan (the “Plan”) and shall be effective as of June 11, 2026. Capitalized terms not otherwise defined herein shall have the meaning ascribed to them in the Plan.

Cash Compensation

Annual retainers will be paid in the following amounts to Non-Employee Directors:

Non-Employee Director:	$40,000
Non-Executive Chair:	$35,000
Audit Committee Chair:	$20,000
Compensation Committee Chair:	$15,000
Nominating and Corporate Governance Committee Chair:	$10,000
Science and Technology Committee Chair:	$15,000
Audit Committee Member (non-Chair):	$10,000
Compensation Committee Member (non-Chair):	$7,500
Nominating and Corporate Governance Committee Member (non-Chair):	$5,000
Science and Technology Committee Member (non-Chair):	$7,500

…

KENNAMETAL INC.

RESTRICTED UNIT AWARD

Grant Date: ____________________

Kennametal Inc. (the “Company”) hereby grants to «name» (the “Awardee”), as of the Grant Date listed above, this Restricted Unit Award (the “Award”) for «number of stock units» Stock Units, subject to the terms and conditions of the Kennametal Inc. 2024 Stock and Incentive Plan (the “Plan”) and the additional terms listed below. Capitalized terms used herein, but not otherwise defined, shall have the same meaning ascribed to them in the Plan.

1.Each Stock Unit represents the right to receive one Share of the Company’s Capital Stock, par value $1.25 per share, subject to the Forfeiture Restrictions (defined below). Notwithstanding, Stock Units as initially awarded have no independent economic value, but rather are mere units of measurement used for the purpose of calculating the number of Shares, if any, to be delivered under the Award.

2.The prohibition against transfer and the obligation to forfeit and surrender the Stock Units to the Company are herein referred to as “Forfeiture Restrictions.” The Stock Units may not be sold, assigned, pledged, exchanged, hypothecated, gifted or otherwise transferred, encumbered or disposed of, except as described in the Plan, to the extent then subject to the Forfeiture Restrictions. The Forfeiture Restrictions will be binding upon, and enforceable against, any permitted transferee of the Stock Units.

…

KENNAMETAL INC.

CASH SETTLED PERFORMANCE UNIT AWARD

FOR CHINA-BASED EMPLOYEES

Award Date: ________________

Kennametal Inc. (the “Company”) hereby awards to «name» (the “Awardee”), as of the Award Date listed above, this Cash Settled Performance Unit Award (the “Award”) for «number of target units» Award Units, subject to the terms and conditions of the Kennametal Inc. 2024 Stock and Incentive Plan (the “Plan”) and the additional terms listed below. Capitalized terms used herein, but not otherwise defined, shall have the same meaning ascribed to them in the Plan.

1.Notwithstanding any provisions of the Plan, each Award Unit represents the right to receive a cash payment from the Company (or an Affiliate or Subsidiary thereof, as applicable) equal to the Fair Market Value of one Share of the Company’s Capital Stock (“Company Stock”), par value $1.25 per share, subject to the satisfaction of the Service Condition described herein and the Performance Conditions attached hereto as Exhibit A. Award Units as initially awarded have no independent economic value, but rather are mere units of measurement used for purposes of calculating the number of Award Units to be used in determining the amount of the cash payment, if any, to be made under the Award. The maximum number of Award Units that may be earned under this Award is equal to 2.0 times the target number of Award Units listed in the preamble above. All vested Award Units are paid in cash to the Awardee and in no circumstance is Company Stock awarded to the Awardee.

…